Original title: the Advisory Committee on Immunization practice of the Centers for Disease Control and Prevention discussed the strengthening needle of COVID-19 vaccine.
Source: CCTV news client
The Advisory Committee on Immunization practice, affiliated to the Centers for Disease Control and Prevention of the United States, discussed COVID-19 's vaccine booster injection on Sept. 22, local time. At the meeting, the committee heard a briefing from experts from the US Centers for Disease Control and Prevention on the effectiveness and safety of Pfizer's COVID-19 vaccine.
Previously, the Advisory Committee on Immunization practice had planned to meet for two consecutive days on 22 September and 23 September. At both meetings, the committee will not vote on whether to recommend the use of COVID-19 vaccine booster needles. However, if the US Food and Drug Administration (FDA) authorizes the use of Pfizer Inc's vaccine booster before the start of the 23rd meeting, the Advisory Committee on Immunization practice will vote on whether to recommend the vaccine booster at the same day's meeting.
On Sept. 17, a panel of experts from the US Food and Drug Administration rejected Pfizer Inc's vaccine enhancement plan by a vote of 16 to 2, which was submitted to the Food and Drug Administration for final decision. According to the members of the panel, the elderly and vulnerable groups may benefit from strengthening needles, but there is insufficient data on whether strengthening needles are effective for young people.
At present, whether the strengthening needle needs to be vaccinated, and the applicable population is still under discussion. (CCTV reporter Xu Dezhi)
(editor Gao Jing)